226: Pharma's telehealth gold mine, the return of the biotech IPO, & a merger deferred
The Readout Loud
00:00
Merck Acquisition of Seagen
It feels like this deal has lost all of its luster at this point. Even if it goes through, how much do you think it's going to really get people excited? Yeah. If we actually see it be announced, will the Merck stands come out and just celebrate the ultimate success of this Seagen acquisition? This was a very leaky deal from a kind of reporting standpoint,.
Transcript
Play full episode


